QurisAI Bio-AI | Icebreaker

Sign up or Log in

Teams

System

QurisAI Bio-AI | Icebreaker

QurisAI Bio-AI

QurisAI Bio-AI

Quris AI is tackling the most impactful AI challenge of our time: Predicting which drug candidates will safely work in humans. Quris’s machine-learning bio-platform predicts which drug candidates will safely work in humans.

4 members

Contact info

Link

quris.ai

Members

•

Kirk Haines 🥑💎🦀

•

Specialties: Developer Relations, Web3/Blockchain Technologies, Solidity, ink!, Rust, Ruby, Javascript/Typescript, OpenTelemetry Implementer, Web Applications and Technologies (React/Rails/other misc). Engineering Management. Application Architectures. Scalability. Systems Administration. Linux. AWS. Finding solutions to tricky problems.

Tamar Straschnow

•

Passionate about people, employer branding, recruitment marketing, and organizational culture. I am a motivated energetic person with strong interpersonal and communication skills. I excel at multitasking and entrepreneurial with advanced management abilities, as well as great capability to work in a high-pressure environment. With experience in HR arena, I am resourceful with the ability to think outside the box on how to optimize and develop human resources in the organization.

•

I have spent the last decade at the intersection of venture capital, investment banking, and technology — building trust across the Israeli tech ecosystem and beyond. Originally from Montreal, I moved to Israel with the mission of earning a seat at the table with founders, investors, and operators through execution, empathy, and rigor. As a VC investor, I’ve led $11M in early-stage tech investments across fintech, cybertech, biotech, videotech, and agtech, while raising over $57M from platform LPs and helping founders secure $400M+ in follow-on capital. I have proudly served as a trusted advisor in boardrooms, partnering with C-level teams on how to reach product-market fit, build defensibility, and diversify revenue streams to reduce churn and risk. In 2024, I joined the MIT Sloan Fellows MBA Class of 2025 — a global cohort of 100 senior leaders from 40 countries — to deepen my operating toolkit and decision-making mindset. I am now focused on bridging strategy and execution, embracing calculated risk, and scaling business models with impact. My goals: 1. Build empowering, values-aligned teams that reflect the integrity of the product and people behind them 2. Lead with accountability and conviction in building or backing companies that solve real problems and scale in a sustainable manner